Corporate Social Responsibility
Unlike traditional Corporate Social Responsibility, our approach is focused on using science to reduce the burden of disease on society. We understand that our responsibilities extend beyond just generating profits, and we take pride in our efforts to make a difference in the world.
Below are some of our initatives.
Joining the Fight Against SARS-COV2 (COVID19)
We have simulated 1513 FDA approved active compounds against 11 published SARS-COV2 (COVID-19) protein structures to see if an existing compound can affect viral protein assembly and/or activity. As of December 2020 we have access to over 1.5MM detailed de-identified patient records to further our COVID-19 research.
Exploring a Homemade Non-Invasive CPAP Ventilator Concept
We convened a team of engineers and doctors, most of whom have volunteered their time to explore whether a CPAP ventilator can be created using commonly available household parts.
Evaluating Convalescent Plasma Effectiveness Against COVID-19
As of December 2020 we have been leading a team of multi-institution researchers to assess where convalescent plasma is an effective treatment for hospitalized COVID-19 patients. Our results will be based on 2.5MM de-identified patient dataset from NIH/N3C.
Assessing the Effect of Melatonin on COVID-19
Since January 2021 we have been leading a team of multi-institution researchers to validate/invalidate effect of Melatonin (reported by an outside research group) on COVID-19. Our results will be based on dataset from NIH/N3C.